20/20 Biolabs, Inc. Common Stock (AIDX) Stock Price, Quote & AI Analysis

Live AIDX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for 20/20 Biolabs, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for 20/20 Biolabs, Inc. Common Stock (AIDX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

A
AIDX
20/20 Biolabs, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
19.400000
High
20.663000
Low
13.000000
Volume
19,861
VWAP
-
52W Range
$14.50 - $50.00
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

20/20 Biolabs, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

20/20 Biolabs, Inc. Common Stock Overview

Company information

Company Overview

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.

Company Details
Market Cap
$79.07M
Shares Outstanding
4,917,249
CEO
Jonathan Cohen
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

20/20 Biolabs, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...